Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions

Abstract

BackgroundBreast cancer is very common and highly fatal in women. Current non-invasive detection methods like mammograms are unsatisfactory. Lipidomics, a promising detection method, may serve as a novel prognostic approach for breast cancer in high-risk patients.ResultsAccording the predictive model, the combination of 15 lipid species had high diagnostic value. In the training set, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the combination of these 15 lipid species were 83.3%, 92.7%, 89.7%, and 87.9%, respectively. The AUC in the training set was 0.926 (95% CI 0.869-0.982). Similar results were found in the validation set, with the sensitivity, specificity, PPV and NPV at 81.0%, 94.5%, 91.9%, and 86.7%, respectively. The AUC was 0.938 (95% CI 0.889-0.986) in the validation set.MethodsUsing triple quadrupole liquid chromatography electrospray ionization tandem mass spectrometry, this study was to detect global lipid profiling of a total of 194 plasma samples from 84 patients with early-stage breast cancer (stage 0–II) and 110 patients with benign breast disease included in a training set and a validation set. A binary logistic regression was used to build a predictive model for evaluating the lipid species as potential biomarkers in the diagnosis of breast cancer.ConclusionThe combination of these 15 lipid species as a panel could be used as plasma biomarkers for the diagnosis of breast cancer.

Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients

“…In our study, the fecal metabolic analysis identified 72 altered metabolites, mainly including lipid metabolic molecules (e.g., triacylglycerols, glycerophospholipids and sphingolipids), some amino acids, flavonoids, benzoic acids and derivatives. The interruption of lipid metabolism is related to the onset and severe progression of some types of human cancers, including breast cancer, ovarian cancer and colorectal carcinoma . A previous study investigating TC metabolomics mainly included tissue specimens and serum, and one study investigating TC tissue metabolism found that eight phospholipids, including phosphatidylcholine (PC) (32:0), phosphatidic acid (PA) (36:3) and sphingomyelin (SM) (34:1), were upregulated in TC and could be used to discriminate this malignancy .…”

The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines

“…367 lipid species (containing mainly various phospholipids) were identified by lipidomics. The authors identified 15 lipid species which could be considered to form a panel as a set of plasma biomarkers for the diagnosis of early breast cancer [195]. Hopefully, similar analysis can be conducted for other cancers.…”

On the road to unraveling the molecular functions of ether lipids

“…Ether lipids are found in Archaea , albeit with a different stereochemistry (glycerol‐1‐phosphate in contrast to the glycerol‐3‐phosphate found in bacteria and eukarya). They are also found in strictly anaerobic bacteria , protozoans and metazoans , but they seem to be absent in fungi and plants . This makes ether lipids attractive molecules for scientists studying evolution, who can use their footprint as a tool to understand how membranes (a universal feature of all living cells) evolved .…”